VK
Therapeutic Areas
Nyxoah Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Genio® System | Moderate to Severe Obstructive Sleep Apnea (CPAP failures) | Commercial |
Leadership Team at Nyxoah
OT
Olivier Taelman
Chief Executive Officer
JL
John Landry
Chief Financial Officer
SH
Scott Holstine
Chief Commercial Officer
BO
Bruno Onkelinx
Chief Technology Officer
MM
Maggie McGowan
Chief HR Officer
DM
Dr. Maurits S. Boon
Chief Medical Officer
RT
Robert Taub
Founder and Chairman of the Board
KR
Kevin Rakin
Independent Director
DJ
Dr. Jürgen Hambrecht
Independent Director
RJ
Rita Johnson-Mills
Independent Director